Accurate Diagnosis with cTnI/CK-MB/Myo Rapid Test - The Ultimate Solution for Rapid Cardiac Biomarker Testing

Beijing Jinwofu Bioengineering Technology Co., Ltd. is a reputable China-based manufacturer, supplier, and factory of the cTnI/CK-MB/Myo rapid test. This innovative product is designed to help healthcare professionals quickly and accurately diagnose acute myocardial infarction by detecting the presence of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (Myo) in human blood serum, plasma, or whole blood. Using advanced immunochromatographic technology, the cTnI/CK-MB/Myo rapid test offers results within just 15 minutes, making it a valuable tool in emergency departments, hospitals, and clinics. With a high sensitivity and specificity rate, this test ensures accurate diagnosis and appropriate treatment for patients with suspected acute myocardial infarction. Made with high-quality materials and strict quality control protocols, the cTnI/CK-MB/Myo rapid test from Beijing Jinwofu Bioengineering Technology Co., Ltd. is a reliable and efficient diagnostic tool that healthcare professionals can trust. Order yours today and improve your patient care.

Related Products